Skip to content Skip to footer
Subscribe Now

TOP 20

Immunology Top 20 2024
Top 20 Immunology Companies of 2024
Shots: Immunology remains one of the most explored therapy areas. Companies focusing on immunology are steadfastly working to advance treatment options by developing drugs, vaccines, and antibodies In 2023, the global immunology market size was valued at $98.22B and expected to register $263.22B by 2033, with a CAGR of 10.36% from 2024 to 2033. AbbVie…
July 25, 2024
Vaccines Top 20 2024
Top 20 Vaccines of 2024
Shots: Vaccines play an instrumental role in curbing infectious diseases by generating antibodies against antigens and creating a memory to defeat them. Several biopharma companies are steadfastly working to deliver vaccines against infectious and vaccine-preventable diseases around the world In 2024, the global vaccine market is estimated to be around $78B and is expected to…
July 11, 2024
Innovative Digital Therapeutics Top 20 2024
Top 20 Innovative Digital Therapeutics Companies of 2024
Shots: New-age technologies are transforming the healthcare industry continuously. By leveraging digital health platforms, AI-powered apps, and other innovative solutions, there is a significant enhancement in diagnosis, treatment, and prevention With a global market revenue of $180.2B in 2023, the market is projected to reach $549.7B by 2028, registering a CAGR of 25 percent. This…
June 27, 2024
Nutraceutical Top 20 2024
Top 20 Nutraceutical Companies of 2024
Shots: Nutraceuticals offer miraculous health benefits by enhancing body function and assisting in body repair and growth In 2023, the global Nutraceuticals market was valued at $419.93B and is expected to increase from $457.35B in 2024 to $976.74B by 2032 with a CAGR of 9.95 percent. Nestlé ranks first on our list with reported segment…
June 6, 2024
Diagnostic Top 20 2024
Top 20 Diagnostic Companies of 2024 
Shots:   Propelled by unceasing innovations and inch-perfect precision, the diagnostic industry is advancing at an astonishing pace  In 2023, the global diagnostic test market size was valued at $210.58B and is envisioned to reach $284.38B by 2033, registering a CAGR of 3.05 percent from 2024 to 2033. Roche reclaims its first position with a revenue…
May 23, 2024
Medical Device Top 20 2024
Top 20 Medical Device Companies of 2024 
Shots:   Bringing innovation and technology to healthcare, the MedTech sector is growing rapidly and transforming the ways diagnosis and treatment are received  With a global market size of $503.2B in 2023, the MedTech sector anticipates reaching $776.4B by 2033 with a CAGR of 4.4 percent. With a staggering revenue of $32.31B, Medtronic ranks first in…
May 9, 2024
RNAi Therapeutic Top 20 2024
Top 20 RNAi Therapeutic Companies of 2024
Shots:  RNAi therapeutics are innovative medications that enable rapid identification of specific inhibitors of disease targets across a wide range of molecule classes. Several biopharma companies are investing in RNAi therapeutics extravagantly to maintain a healthy foothold in innovative medicines  In 2023, the global RNAi drug delivery market size was valued at $84.1B and is…
April 25, 2024
Biopharma Deal Terminations Top 20 2023
Top 20 Biopharma Deal Terminations of 2023 Based on Total Deal Value
Shots:  Sticking to M&A and licensing agreements can be really challenging, especially when dealing with stringent antitrust laws and evolving regulatory challenges. In such adverse scenarios, the rational and right step seems to be nullifying the existing deals. In 2023, the termination of the deal between Janssen and Arrowhead remained the talk of the town…
April 18, 2024
Biopharm Top 20 2023
Top 20 Biopharma Companies of 2024
Shots: Driven by innovations and propelled by the pursuit of delivering the best-in-class therapies, 2023 remained a good year for the Biopharma Industry, despite a slight revenue decline, partly due to the conclusion of the COVID-19 pandemic With a CAGR of 7.8 %, the global biopharma industry is anticipated to register a market size of…
April 11, 2024
IPO Top 20 2023
Top 20 IPOs in Healthcare by Total Fund Value 2023
Shots: Clinical-stage biopharma companies are in constant need of funding and the best way to pull in money in such dire situations is by going public. 2023 had been a great year for Wall Streets across the globe with continuous announcements of IPOs Kenvue by bagging $4.37B upon completion of its IPO ranked first in…
March 28, 2024
Load more

Sign Up to Our Newsletter

Be the first to know the latest updates

[mc4wp_form id="13387" element_id="style-1"]